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Abstract
Confusion exists over the species status and host-specificity of the tapeworm
Rodentolepis (= Hymenolepis) nana. It has been described as one species, R. nana,
found in both humans and rodents. Others have identified a subspecies; R. nana
var. fraterna, describing it as morphologically identical to the human form but
only found in rodents. The species present in Australian communities has never
been identified with certainty. Fifty one human isolates of Rodentolepis (=
Hymenolepis) nana were orally inoculated into Swiss Q, BALB/c, A/J, CBA/
CAH and nude (hypothymic) BALB/c mice, Fischer 344 and Wistar rats and
specific pathogen free (SPF) hamsters. Twenty four human isolates of R. nana
were cross-tested in flour beetles, Tribolium confusum. No adult worms were
obtained from mice, rats or hamsters, even when immunosuppressed with
cortisone acetate. Only one of the 24 samples developed to the cysticercoid stage
in T. confusum; however, when inoculated into laboratory mice the cysticercoids
failed to develop into adult worms. The large sample size used in this study,
and the range of techniques employed for extraction and preparation of eggs
provide a comprehensive test of the hypothesis that the human strain of R. nana
is essentially non-infective to rodents.
Introduction
Rodentolepis (= Hymenolepis) nana is the most common
cestode infecting humans worldwide (Smyth, 1994).
Estimates of the number of human infections range
from 20 million (Andreassen, 1998) to 50±75 million
(Pawlowski, 1984; Crompton, 1999) worldwide. Humans
may also be infected with the rat tapeworm, Hymenolepis
diminuta, but this is considered rare and usually
accidental (Schantz, 1996; Andreassen, 1998) and almost
always occurs in children (Tena et al., 1998).
There is confusion in the literature regarding both the
nomenclature and host specificity of R. nana. A taxo-
nomic revision of hymenolepidids with armed rostellae
(hooks present) was proposed by Spasskii in 1954
(Vaucher, 1992) in which Hymenolepis nana was reclassi-
fied under the genus Rodentolepis and this classification is
currently recognized by some cestode taxonomists
(Czaplinski & Vaucher, 1994). The genus Hymenolepis
Weinland 1858 now only contains hymenolepidid species
with unarmed rostellae (hooks absent) and the type
species is the rat tapeworm Hymenolepis diminuta
(Czaplinski & Vaucher, 1994). Despite the revised
nomenclature being adopted by some taxonomists
(Spasskii, 1994; Czaplinski & Vaucher, 1994) Rodentolepis
nana is almost universally referred to as Hymenolepis nana
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Pawlowski, 1984; Smyth & McManus, 1989; Smyth, 1994;
Baily, 1996; Schantz, 1996; Lloyd, 1998; Andreassen,
1998).
In Australia, human infections with Rodentolepis (=
Hymenolepis) nana are most common in communities in
tropical regions. The prevalence of R. nana has risen from
20% (Meloni et al., 1993) to approximately 55% in these
same communities (Reynoldson et al., 1997) within the
last decade. There is uncertainty about the transmission
of R. nana in these endemic areas where human infection
is common. It is not well understood whether the `strain/
species' of R. nana present in the north-west of Western
Australia is found in rodent and human hosts or whether
humans harbour their own form of this parasite. For
example, R. nana has been described as being infective to
both humans and rodents (Yamaguti, 1959). Others have
concluded that the rodent form is a subspecies, R. nana
var. fraterna, morphologically indistinguishable from the
human form and only infective to rodents (cf. Baer &
Tenora, 1970; Pawlowski, 1984; Schantz, 1996; Lloyd,
1998). In the present study, some of these uncertainties
were resolved by testing the infectivity of a number of
human isolates of R. nana in specific pathogen free (SPF)
mice, rats and hamsters under varying conditions.
Materials and methods
Source of parasites
A laboratory isolate of R. nana was kindly provided by
Dr Akira Ito, Gifu University, Japan in two forms: (i) eggs
in PBS; and (ii) approximately 30 flour beetles, Tribolium
confusum, infected with the cysticercoid stage of R. nana.
The isolate has been passaged through laboratory mice
for more than 20 years. Human faecal samples were
collected from the north-west region of Western Australia
over a period of three years. Positive identification of
infection was carried out using the ZnSO4 flotation
technique (Voge, 1970). Eggs were usually extracted from
faecal samples using the NaCl flotation method (Voge,
1970) prior to inoculation into specific pathogen free
(SPF) mice, rats and hamsters (tables 1 and 2). Other egg
extraction techniques used in this study are outlined (see
Infection methods tested using human isolates).
Infection of mice and beetles using a laboratory reference strain
The direct and indirect life cycles of R. nana were tested
in this study using eggs and cysticercoids sent by Dr Ito
(Gifu University, Japan). Infected Tribolium confusum sent
by Dr Ito were killed and dissected using a WILD M7A
Table 1. Inoculation of SPF mice and flour beetles with human isolates of Rodentolepis (=Hymenolepis) nana.
SPF mice or beetles Species
Number of
mice or beetles Sex Age
Number of
samples tested
Samples yielding
cysticercoids (beetles)
or adult worms (mice)
Samples yielding
adult worms
Swiss Q Mouse 85 Male 4±5 wks 51 0 0
BALB/c Mouse 98 Male 4±5 wks 51 0 0
BALB/c nude² Mouse 5 Male 4±5 wks 1 0 0
Flour beetles T. confusum 110 ND ND 11
a 1
* 0
Flour beetles T. confusum 130 ND ND 13
b 00
aEggs obtained by NaCl flotation.
bDirect faecal feeding.
*One sample yielded 73 cysticercoids dissected from five Tribolium confusum beetles infected via ad libitum feeding of eggs on filter
paper.
²Hypothymic model.
ND, not determined.
Table 2. Cortisone acetate treatment regime in mice, rats and hamsters prior to inoculation with human isolates of Rodentolepis
(=Hymenolepis) nana.
SPF strain Species Number Sex Age Cortisone treatment Adult worms obtained
Swiss Q
a Mouse 3
a/3* Male 4±5 wks 125 mg kg
21; 5 doses
a 0
AJ
a Mouse 3
a/3* Male 4±5 wks 125 mg kg
21; 5 doses
a 0
CBA/CAH
a Mouse 3
a/3* Male 4±5 wks 125 mg kg
21; 5 doses
a 0
AJ
b Mouse 3
b/3* Male 4±5 wks 125 mg kg
21; 5 doses
b 0
CBA/CAH
b Mouse 3
b/3* Male 4±5 wks 125 mg kg
21; 5 doses
b 0
Fischer 344
c Rat 3
c/3* Male 4±5 wks 100 mg total in 2 doses
c 0
Wistar
c Rat 3
c/3* Male 4±5 wks 100 mg total in 2 doses
c 0
DSN
d Hamsters 15
d Male 8 wks 25 mg kg
21 in 2 doses
d 0
aCortisone injections days 2, 4, 6, 8, 10, 12 (dose-weight dependent).
bCortisone injections days -1, 1, 3, 5, 7, 9 (dose-weight dependent).
cCortisone injections days 4 and 6 (dose-weight independent).
dCortisone given to all 15 hamsters days -1 and 4.
*Control group received no cortisone.
38 M.G. Macnish et al.stereo microscope (WILD Heerbrugg, Switzerland).
Cysticercoids were collected into phosphate buffered
saline (PBS) and orally inoculated, via stomach tube, into
Swiss Quackenbush (Swiss Q) and BALB/c male, 4- to 5-
week-old mice. Approximately 11 days later, adult
worms were dissected from the small intestine and
washed repeatedly in PBS. Eggs were teased from the
gravid proglottids from worms obtained in this manner
and routinely passaged through mice and beetles. In
addition, R. nana eggs sent by Dr Ito were stored in PBS
at 48C and were periodically inoculated into mice (19, 23,
26, 62 and 70 days post-collection). This was primarily to
provide a positive control of the decline of viability of
eggs stored at non-ambient temperatures over a several
week period. When mice were inoculated with eggs,
rather than cysticercoids, euthanasia and dissection were
delayed until day 14 due to the longer pre-patency of
infection.
Infection of mice, rats and hamsters using human samples
The SPF mice and rats used in this study (tables 1 and
2) were purchased from the Animal Resources Centre
(ARC), Western Australia. The infection trials were
conducted at Murdoch University, Western Australia.
The hamster infection trial (table 2) was conducted by
J.M. Behnke with a human isolate of R. nana from our
collection. At Murdoch University, R. nana eggs were
suspended in 0.1 ml phosphate buffered saline, drawn
into a 1 ml hypodermic syringe fitted with a blunted 23
gauge needle and 0.5 mm polyethylene tubing then
orally inoculated into rodent hosts.
Infection methods tested using human isolates
A variety of egg collection and inoculation methods
were tested using human isolates of R. nana in both mice
and beetles:
1. Oral inoculation of mice, via stomach tube, using eggs
extracted by NaCl flotation. The size of each inoculum
ranged from 50 to 14 400 eggs (Ferretti et al., 1980; Ito,
1982, 1984; Palmas et al., 1984).
2. Oral inoculation of mice, via stomach tube, using eggs
extracted by Ficoll/sodium diatrizoate gradient centrifu-
gation (Lumb et al., 1988) and sucrose gradient methods
outlined by Berntzen & Voge (1962), Lethbridge (1971)
and Hurd & Burns (1994).
3. Oral inoculation of mice, via stomach tube, using eggs
treated by mechanical and chemical `cracking' with a
glass bead and trypsin digestion method outlined by Ito
(1975) except that the trypsin (ICN Biomedicals, Ohio,
USA) was dissolved in Tyrodes solution (Sigma, St Louis,
Missouri, USA) instead of Hanks' balanced salt solution
and the glass beads (Sigma, USA) used were smaller
(425±600 mm).
4. Spiking of mouse food with eggs for ad libitum feeding
(Ferretti et al., 1980) except that bread pieces were used
instead of ground food pellets provided by the small
animal facility, Murdoch University.
5. The pharmacological immunosuppression (Lucas et al.,
1980) of mice, rats and hamsters using subcutaneous
injections of cortisone acetate (Sigma, USA) as well as the
use of a congenitally hypothymic mouse model (Ito,
1985).
6. Feeding NaCl-extracted eggs to Tribolium confusum
(flour beetles) that were pre-starved for 6 days (Naka-
mura & Okamoto, 1993) on either filter paper (Yan &
Norman, 1995) or a latex rubber sheet (Nakamura &
Okamoto, 1993).
7. Feeding T. confusum (pre-starved for 6 days) directly on
infected faeces (Pappas et al., 1995; Yan & Norman, 1995).
Cortisone acetate treatment
Five different strains of SPF mice were used for the
experimental procedures including Swiss Q (Thompson,
1972; Seidel & Voge, 1975) BALB/c (Asano et al., 1986;
Watanabe et al., 1994; Matsuo & Okamoto, 1995); A/J and
CBA/CAH (Ito et al., 1988); two strains of SPF rats:
Fischer 344 (Ito, 1983) and Wistar, an equivalent strain to
the Rowett rats used by (Ito & Kamiyama, 1987) and SPF
hamsters (Ronald & Wagner, 1975).
Mice
Six Swiss Q, A/J and CBA/CAH mice were divided
into two equal groups. All mice were weighed prior to
the trial to adjust their dose of cortisone accordingly. A
sub-cutaneous injection of cortisone acetate (Sigma, USA)
at a dose of 125 mg kg
21 (Malinverni et al., 1995) was
given to half the group on days 2, 4, 6, 8, 10 and 12
(treatment
a, table 2). The remaining half of each group
were used as controls and did not receive any cortisone
treatment prior to inoculation with R. nana eggs. All six
mice in each group were inoculated with 2000 R. nana
eggs in 0.2 ml PBS on day 0, regardless of their status
(controls and test). A slightly modified regime (treat-
ment
b, table 2) was also tried using A/J and CBA/CAH
mice whereby mice received their first cortisone dose
24 h prior to inoculation (day -1), followed by five
subsequent doses on days 1, 3, 5, 7 and 9. All mice,
regardless of their status, were killed and dissected 14
days post-inoculation.
Rats
Six each Wistar and Fischer 344 rats were divided into
two equal groups. Half of each group received a sub-
cutaneous injection of 50 mg cortisone acetate on days 4
and 6 (Ito & Kamiyama, 1987). All rats (controls and test)
were inoculated with 2000 R. nana eggs in 0.2 ml PBS on
day 0. All rats were killed and dissected 14 days post-
inoculation. The same human sample was used to infect
all mice and rats used in the cortisone treatment trial,
thus eliminating random `between-sample' variability
from the experimental procedure.
Hamsters
Fifteen hamsters were divided equally into five
groups. Although it was not possible to use the sample
inoculated into the mice and rats, a single human sample
was used to inoculate all 15 hamsters. All hamsters
received a subcutaneous injection of cortisone acetate
(Sigma, USA) at a dose of 25 mg kg
21 24 h prior to
stomach tubing and again on day 4 post inoculation.
Each group was inoculated with varying numbers of
39 Infectivity of human R. nana to rodentseggs. Group 1 received approximately 1860 eggs each;
group 2 received 2220; group 3 received 3260 eggs; group
4 received 14 400 eggs and group 5 received 400 eggs.
One hamster per group was killed on day 4 to examine
the intestine for cysticercoids, another on day 7 to look
for immature worms and the remaining hamster on day
14 to look for mature adult worms.
Viability tests
Trypsin digestion
Egg shells were removed from R. nana both mechani-
cally and chemically using a modified trypsin digestion
method (see point 3, infection methods tested using
human isolates).
Nucleic acid dyes
Nucleic acid dye staining techniques used successfully
for viability testing of Giardia and Cryptosporidium spp.
by other researchers (Schupp & Erlandsen, 1987; Belo-
sevic et al., 1997), were evaluated for their indicator of
viability of R. nana eggs extracted from human faeces.
Stock and working solutions of fluorescein diacetate
(FDA) and propidium iodide (PI) (Sigma, USA) were
prepared according to the method outlined by Schupp &
Erlandsen (1987) whilst SYTO-9 and hexidium iodide
(HI), from the BacLighte Bacterial gram strain kit
(Molecular Probes, Eugene, Oregon, USA), were pre-
pared according to manufacturers instructions. A pellet
of R. nana eggs was obtained by centrifugation at full
speed for 30 s and excess supernatant removed. Giardia
cultures and Cryptosporidium oocysts, maintained routi-
nely in our laboratory, were used as controls (positive
and negative) and R. nana eggs, heated to 708C for
30 min, were also used as a negative control. Nucleic acid
staining using FDA and PI was carried out on ice for
10 min (Schupp & Erlandsen, 1987) as well as at 378C for
30 min. Nucleic acid staining using SYTO-9 and HI was
carried out for 10, 30 and 60 min at 378C based on the
method outlined by Belosevic et al. (1997). A sample of R.
nana not exposed to nucleic acid dye was also used to
check for intrinsic autofluorescence, a phenomenon
found to occur in some cells (Steinkamp et al., 2000).
Slides of all test and controls were viewed using a
confocal laser microscope (BioRad, California, USA)
using 488 nm laser at 1% power. A 522Df35 filter was
used for FDA and SYTO-9 detection and a 680DF32 filter
was used for PI and HI detection.
Results
Infection trials using a laboratory reference isolate in mice and
beetles
Oral inoculation of eggs, stored at 48C, of the Japanese
reference strain yielded adult worms from both Swiss Q
and BALB/c mice when dissected 14 days post inocula-
tion on all occasions (after 19, 23, 26, 62 and 70 days
storage) providing a positive control of viability over
time (data not shown). Eggs from Dr Ito's isolate were
not tested for viability beyond day 70. Tribolium confusum
beetles, starved for 6 days, then fed on terminal gravid
proglottids obtained from these worms were consistently
infected with cysticercoids upon dissection 3 weeks post-
feeding. When mice were inoculated with cysticercoids
from beetles sent from Japan, adult worms were
consistently obtained whether 3, 4, 6, 7, 10 or 13
cysticercoids were used (data not shown).
Infection trials of human isolates in mice and rats
Of 51 human faecal samples tested in mice and 24
samples cross-tested in beetles, cysticercoid development
occurred in T. confusum with one sample only (table 1).
This faecal sample was stored at 48C for 23 days prior to
egg extraction using NaCl flotation then fed to beetles.
Five beetles harboured 73 cysticercoids in total (table 1).
Two Swiss Q mice were inoculated with 13 and 25
cysticercoids respectively within 2 h of dissection from
the beetles. Two more Swiss Q mice were inoculated
three days later with 13 and 22 cysticercoids respectively
that had been stored at 48C since collection. No adult
worms developed from these cysticercoids in all four
mice (table 1). All remaining human samples failed to
yield either cysticercoids in beetles or adult worms in
mice, including those inoculated into the hypothymic
BALB/c mice regardless of the methods used for egg
collection and inoculation of the hosts (table 1).
Infection trial of mice, rats and hamsters treated with cortisone
acetate
All mice and rats inoculated with the same human
isolate were not infected with adult worms when
dissected 14 days post-inoculation regardless of whether
treated with cortisone acetate or not (table 2). Hamsters,
from each group, killed and dissected on day 4 post-
infection failed to yield cysticercoids from intestinal
scrapings. Furthermore, hamsters dissected on days 7
and 14 were not infected with immature or mature
worms respectively (table 2).
Viability tests using trypsin digestion and nucleic acid dye
staining
Microscopical examination of aliquots of eggs exam-
ined after trypsin digestion revealed many R. nana eggs
with hatched oncospheres (results not shown). When
inoculated into mice or fed to beetles, however, no
development to cysticercoid stage or adult worm
occurred. The use of nucleic acid dyes, FDA, PI, SYTO-
9 and hexidium iodide failed to provide an indication of
viability of R. nana eggs for two reasons. Firstly, it was
apparent that R. nana eggs are mildly autofluorescent in
the absence of the nucleic acid dyes (results not shown).
Secondly, it was found that heat-killed R. nana eggs
exhibited fluorescence with all four nucleic acid dyes
(results not shown) rendering the system unworkable for
viability discrimination. The protozoan controls used in
each system (FDA/PI and SYTO-9/HI) worked accord-
ing to the published methods outlined, indicating the
failure to discriminate between heat-killed and non-
treated R. nana eggs did not relate to the dyes themselves,
or a technical failure of the method.
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The failure to infect mice, rats and hamsters with the
human isolates of R. nana collected in Western Australia
is consistent with the hypothesis that `strains' or
`variants' of R. nana that are host adapted exist in
Australian communities. In an attempt to address this
hypothesis, a number of variables were examined in the
current study including the use of three different rodent
species (mice, rats and hamsters) together with an insect
model, supported by large sample sizes in each case.
Numerous approaches were tested for their suitability in
the infection of the animal models, including the use of
several strains, and genetically and pharmacologically
modified animals.
Overall, considerable care was taken in handling the
eggs to avoid all obvious treatments that could have
accounted for poor infectivity. Faecal samples were kept
cool and analysed as soon after collection as was
practicable. The potential for variation in infectivity
rates due to the age of the sample was carefully
addressed by using samples that were wide ranging in
age. The human samples collected in our survey were
always sealed in collection pots, usually immediately, but
always within a few hours of collection and stored on ice
or refrigerated at 48C, thus decreasing the risk of long
periods of exposure to air, humidity and high tempera-
tures. Quality control included concurrent experiments
with a Japanese isolate of up to 70 days of age (stored at
48C) which yielded adult worms when inoculated into
mice on all occasions, suggesting that eggs remain viable
for long periods if storage conditions are appropriate. In
this study, oral inoculation of eggs into mice and beetles,
including the direct feeding of faeces to beetles, was
carried out using human faecal samples that ranged in
age from 1 h (beetles only) through to 72 days old (mice
and beetles). Cysticercoids did not develop in the beetles
in all but one sample, nor did adult worms develop in
any rodent host, regardless of their immune and genetic
status. The development of R. nana eggs from one human
sample to cysticercoid stage in T. confusum is a positive
indication of viability. Reports in the literature regarding
egg viability are contradictory. Maki & Yanagisawa
(1987) suggest that the infectivity of eggs decreases
after 17 h exposure to air. In contrast, Pawlowski (1984)
report a survival of eggs in the environment up to 10
days. Kennedy (1983) found that eggs of H. diminuta can
survive and remain infective in rat faeces for up to 60
days when conditions are optimal.
The extraction techniques employed in this study are
unlikely to have damaged the R. nana eggs. Although the
use of NaCl concentration has been criticized by some
researchers who believe the procedure may reduce the
infectivity of R. nana eggs (Yan & Norman, 1995; Ferretti
et al., 1980), Thompson (1972) repeatedly succeeded in
infecting albino mice with R. nana eggs obtained by NaCl
flotation and other researchers routinely use NaCl
extraction procedures for obtaining R. nana eggs for
testing in mice (Nakamura & Okamoto, 1993). In
addition, Hurd & Burns (1994) used a combination of
saturated NaCl and sucrose to extract H. diminuta eggs
from faeces and successfully infected laboratory rats.
Moreover,theonlysamplewhichdevelopedtocysticercoid
stage in beetles in this study was extracted using
saturated NaCl flotation.
Berntzen & Voge (1962) first suggested that the
preparation of `shell-free' R. nana eggs increases their
infectivity and this has been used routinely for obtaining
eggs for inoculation into beetle and rodent hosts (cf. Ito,
1977, 1982, 1984). In our laboratory the egg shells were
removed both mechanically and chemically using the
methods outlined by these researchers with some
modification (see point 3 ± Infection methods tested
using human isolates). Despite observing many R. nana
eggs with hatched oncospheres, these did not develop to
the cysticercoid stage or adult worm when fed to beetles
or inoculated into mice.
The numbers of cysticercoids inoculated into mice in
our study were consistent with other researchers who
have reported successful infection to adult worm stages
with 1±20 cysticercoids (Lucas et al., 1980; Ito et al., 1988;
Kumazawa, 1992). Furthermore, in the present study, the
consistent development of cysticercoids, obtained from
the Japanese control isolate, into adult worms when
inoculated into laboratory rodents indicated that the
storage of cysticercoids in PBS prior to inoculation did
not adversely affect the viability of the cysticercoids. This
is consistent with the methods outlined by Nakamura &
Okamoto (1993) who store their cysticercoids in physio-
logical saline.
Based on previous research (Lucas et al., 1980; Ito et al.,
1988; Asano et al., 1992; Maki & Ito, 1998) several
different susceptible rodent hosts were used in the
inoculation trials in this study. However, the use of
these highly susceptible mice, even when further
immunosuppressed with cortisone, and the use of
hypothymic rodent hosts did not result in the develop-
ment of eggs to either cysticercoid or adult worm stages
in vivo.
The lack of development of 23 of the 24 human
samples of R. nana eggs tested in T. confusum beetles to
cysticercoid stage in this study is unlikely to be
attributable to factors such as variability in the genetics,
sex and nutritional status of the beetle host. Given that
Yan & Norman (1995) found that two beetle species,
T. confusum and T. castaneum, varied in their suscept-
ibility to H. diminuta as well as showing significant
among-strain and between-sex variation, only one
species, T. confusum, was used in our study at all times.
In addition, there is evidence that male beetles harbour
significantly greater numbers of cysticercoids than
female beetles when infected with H. diminuta eggs
(Pappas et al., 1995). Whilst the sex of the beetles
employed in this study was not determined, the strain
is routinely used in our laboratory for the maintenance of
H. diminuta suggesting that the sex ratio of males to
females is sufficient for routine passage of this parasite.
Furthermore, this strain of beetle is routinely starved for
4±5 days prior to inoculation with H. diminuta eggs in
our laboratory. In experiments conducted with R. nana,
however, beetles were routinely starved for 6 days, as
proposed by Nakamura & Okamoto (1993), suggesting
the failure to demonstrate infection with R. nana in
beetles in this study was not due to insufficient
starvation times. The failure of human isolates to develop
to cysticercoid stage in beetles may, therefore, be
41 Infectivity of human R. nana to rodentsexplained by a progressive loss of adaptation of the
Australian human isolates to these intermediate hosts. In
light of this suggestion, the development of one of the 24
human samples to cysticercoid stage in beetles is difficult
to explain.
It is not entirely clear whether rodent species play a
role in the transmission of R. nana in Australia or
whether they harbour their own variant species/strain.
In view of the reliability of the experimental protocols
being controlled by the use, in parallel, of eggs and
cysticercoids from a mouse strain of R. nana combined
with the use of a large sample size in this study, the
failure to infect mice, rats and hamsters with 51 human
isolates of R. nana provides supportive evidence towards
the hypothesis that a human variant of R. nana exists in
Australia.
A poor understanding of the dynamics of transmission
of a parasite undermines both short and long term
control strategies which can only be effective when
accurate epidemiological information is obtained (Hol-
land et al., 1996). Identifying the risk factors within
communities, from detailed epidemiological data, is
likely to be the most cost efficient for implementing
control strategies (WHO, 1996). In addition to the
biological data provided here, the genetic characteriza-
tion of R. nana would help to clarify the epidemiology of
infections in local, endemic, communities and in rodent
populations and would provide the springboard for a
strategic approach to the implementation of long-term
control programmes.
Acknowledgements
The authors would like to thank Dr Akira Ito, Gifu
University, Japan, and Dr Margherita Conchedda,
Cagliari, Italy for their generous gifts of R. nana isolates.
Funding provided by the Australian Federation of
University Women (WA) Inc. and the National Health
and Medical Research Centre (NHMRC) is also gratefully
acknowledged.
References
Andreassen, J. (1998) Intestinal tapeworms. pp. 521±537
in Cox, F.E.G., Kreier, J.P. & Wakelin, D. (Eds) Topley and
Wilsons: microbiology and microbial infections. London,
Arnold.
Arme, C. & Pappas, P.W. (1983) Biology of the Eucestoda.
296 pp. LondonAcademic Press.
Asano, K., Shinoda, M., Nakamura, F. & Okamota, K.
(1986) Hymenolepis nana: passive transfer of mouse
immunity by T-cell subset of phenotype Lyt-1. Experi-
mental Parasitology 61, 373±378.
Asano, K., Muramatsu, K., Ito, A. & Okamoto, K. (1992)
Macrophages in protective immunity to Hymenolepis
nana in mice. Immunology and Cell Biology 70, 417±420.
Baer, J.G. & Tenora, F. (1970) Some species of Hymeno-
lepis (Cestoidea) from rodents and from primates. Acta
Scientiarum Naturalium Academiae Scientiarum Bohemo-
slovacae ± Brno 4, 1±32.
Baily, G.C. (1996) Intestinal cestodes. pp. 1480±1485 in
Cook, G.G. (Ed.) Manson's tropical diseases. London, WB
Saunders.
Belosevic, M., Guy, R.A., Taghi-Kilani, R., Neumann,
N.F., Gyurek, L.L., Liyanage, L.R.J., Millards, P.J. &
Finch, G.R. (1997) Nucleic acid stains as indicators of
Cryptosporidium parvum oocyst viability. International
Journal for Parasitology 27, 787±798.
Berntzen, A.K. & Voge, M. (1962) In vitro hatching of
oncospheres of Hymenolepis nana and H. citelli. Journal
of Parasitology 48, 110±119.
Crompton, D.W.T. (1999) How much human helminthia-
sis is there in the world? Journal of Parasitology 85, 397±
403.
Czaplinski, B. & Vaucher, C. (1994) Family Hymeno-
lepididae Ariola, 1899. pp. 595±663 in Khalil, L.F.,
Jones, A. & Bray, R.A. (Eds) Keys to the cestode parasites
of vertebrates. Wallingford, CAB International.
Ferretti, G., Gabriele, F. & Palmas, C. (1980) Methodol-
ogy in experimental infections of mice with Hymeno-
lepis nana. Bollettino di Zoologia 47, 165±184.
Holland, C.V., O'Shea, E., Asaolu, S.O., Turley, O. &
Crompton, D.W.T. (1996) A cost-effectiveness analysis
of anthelminthic intervention for community control of
soil-transmitted helminth infection: levamisole and
Ascaris lumbricoides. Journal of Parasitology 82, 527±530.
Hurd, H. & Burns, I. (1994) Observations on the axenic
culture of metacestodes of Hymenolepis diminuta.
Canadian Journal of Zoology 72, 618±623.
Ito, A. (1975) In vitro oncospheral agglutination given by
immune sera from mice infected, and rabbits injected,
with eggs of Hymenolepis nana. Parasitology 71, 465±473.
Ito, A. (1977) A simple method for collecting infective
cysticercoids of Hymenolepis nana from the mouse
intestine. Journal of Parasitology 63, 167±168.
Ito, A. (1982) Hymenolepis nana: immunogenicity of a
lumen phase of the direct cycle and failure of
autoinfection in BALB/c mice. Experimental Parasitol-
ogy 54, 113±120.
Ito, A. (1983) Hymenolepis nana: maturation in an
immunosuppressed unnatural rat host. Experimental
Parasitology 56, 318±326.
Ito, A. (1984) Stage-specific immunogens of Hymenolepis
nana in mice. Journal of Helminthology 58, 235±238.
Ito, A. (1985) Thymus dependency of induced immune
responses against Hymenolepis nana (cestode) using
congenitally athymic nude mice. Clinical and Experi-
mental Immunology 60, 87±94.
Ito, A. & Kamiyama, T. (1987) Cortisone-sensitive, innate
resistance to Hymenolepis nana infection in congenitally
athymic nude rats. Journal of Helminthology 61, 124±128.
Ito, A., Lightowlers, M.W., Rickard, M.D. & Mitchell,
G.F. (1988) Failure of auto-infection with Hymenolepis
nana in seven inbred strains of mice initially given
beetle-derived cysticercoids. International Journal for
Parasitology 18, 321±324.
Kennedy, C.R. (1983) General ecology. pp. 27±80 in
Arme, C. & Pappas, P.W. (Eds) Biology of the Eucestoda.
London, Academic Press.
Kumazawa, H. (1992) A kinetic study of egg production,
fecal egg output, and the rate of proglottid shedding in
Hymenolepis nana. Journal of Parasitology 78, 498±504.
Lethbridge, R.C. (1971) An improved gradient centrifu-
gation technique for the separation of Hymenolepis
diminuta eggs from rat feces. Journal of Parasitology 57,
1140±1142.
42 M.G. Macnish et al.Lloyd, S. (1998) Other cestode infections hymenolepiosis,
diphyllobothriosis, coenurosis and other adult and
larval cestodes. pp. 651±663 in Palmer, S.R., Soulsby,
E.J.L. & Simpson, D.I.H. (Eds) Zoonoses. Oxford, Oxford
University Press.
Lucas, S.B., Hassounah, O., Muller, R. & Doenhoff, M.J.
(1980) Abnormal development of Hymenolepis nana
larvae in immunosuppressed mice. Journal of Hel-
minthology 54, 75±82.
Lumb, R., Smith, K., O'Donoghue, P.J. & Lanser, J.A.
(1988) Ultrastructure of the attachment of Cryptospor-
idium sporozoites to tissue culture cells. Parasitology
Research 74, 531±536.
Maki, J. & Ito, Y. (1998) A preliminary study on
susceptibility of mice of various strains to Hymenolepis
nana eggs. Tropical Medicine 40, 45±46.
Maki, J. & Yanagisawa, T. (1987) Infectivity of Hymeno-
lepis nana eggs from faecal pellets in the rectum of
mice. Journal of Helminthology 61, 341±345.
Malinverni, R., Kuo, C.C., Campbell, L.A. & Grayston,
J.T. (1995) Reactivation of Chlamydia pneumoniae lung
infection in mice by cortisone. Journal of Infectious
Diseases 172, 593±594.
Matsuo, S. & Okamoto, K. (1995) Enhancement of FK-
506 activities by ganglioside (GM3) in vivo. Life Sciences
57, 165±169.
Meloni, B.P., Thompson, R.C.A., Hopkins, R.M., Rey-
noldson, J.A. & Gracey, M. (1993) The prevalence of
Giardia and other intestinal parasites in children, dogs
and cats from Aboriginal communities in the Kimber-
ley. Medical Journal of Australia 158, 157±159.
Nakamura, F. & Okamoto, K. (1993) Reconsideration of
the effects of selfing on the viability of Hymenolepis
nana. International Journal for Parasitology 23, 931±936.
Palmas, C., Wakelin, D. & Gabrielle, F. (1984) Transfer of
immunity against Hymenolepis nana in mice with
lymphoid cells or serum from infected donors. Para-
sitology 89, 287±293.
Pappas, P.W., Marschall, E.A., Morrison, S.E., Durka,
G.M. & Daniel, C.S. (1995) Increased coprophagic
activity of the beetle, Tenebrio molitor, on feces contain-
ing eggs of the tapeworm, Hymenolepis diminuta.
International Journal for Parasitology 25, 1179±1184.
Pawlowski, P.W. (1984) Cestodiases: taeniasis, diphyllo-
bothriasis, hymenolepiasis and others. pp. 471±486 in
Warren, K.S. & Mahmoud, A.A.F. (Eds) Tropical and
geographical medicine. New York, McGraw-Hill Book
Company.
Reynoldson, J.A., Behnke, J.M., Pallant, L.J., Macnish,
M.G., Gilbert, F., Giles, S., Spargo, R.J. & Thompson,
R.C.A. (1997) Failure of pyrantel in treatment of
human hookworm infections (Ancylostoma duodenale)
in the Kimberley region of North West Australia. Acta
Tropica 68, 301±312.
Ronald, N.C. & Wagner, J.E. (1975) Treatment of
Hymenolepis nana in hamsters with Yomesan (niclosa-
mide). Laboratory Animal Science 25, 219±220.
Schantz, P.M. (1996) Tapeworms (cestodiasis). Gastro-
enterology Clinics of North America 3, 637±653.
Schupp, D.G. & Erlandsen, S.L. (1987) Determination of
Giardia muris cyst viability by differential interference
contrast, phase, or brightfield microscopy. Journal of
Parasitology 73, 723±729.
Seidel, J.S. & Voge, M. (1975) Axenic development of
cysticercoids of Hymenolepis nana. Journal of Parasitology
61, 861±864.
Smyth, J.D. (1994) Eucestoda: Cyclophyllidea. pp. 321±
348 in Introduction to animal parasitology. Cambridge,
Cambridge University Press.
Smyth, J.D. & McManus, D.P. (1989) The physiology and
biochemistry of cestodes. Cambridge, Cambridge Uni-
versity Press.
Spasskii, A.A. (1994) O sistematicheskom polozhenii
gimenolepidid (Cestoda) iz Avstraliiskikh sumchatykh.
[On the systematic position of hymenolepidids (Ces-
toda) from Australian marsupials]. Parazitologiya 28,
66±69.
Steinkamp, J.A., Valdez, Y.E. & Lehnert, B.E. (2000)
Flow cytometric, phase-resolved fluorescence mea-
surement of propidium iodide uptake in macrophages
containing phagocytized fluorescent microspheres.
Cytometry 39, 45±55.
Tena, D., Simon, M.P., Gimeno, C., Perez Pomata, M.T.,
Illescas, S., Amondarain, I., Gonzalez, A., Domin-
guez, J. & Bisquert, J. (1998) Human infection with
Hymenolepis diminuta: case report from Spain. Journal of
Clinical Microbiology 36, 2375±2376.
Thompson, R.C.A. (1972) Aspects of immunity to
Hymenolepis nana. Honours thesis. 30 pp. London,
London University.
Vaucher, C. (1992) Revision of the genus Vampirolepis
Spasskij, 1954 (Cestoda: Hymenolepididae). Memo Ârias
do Instituto Oswaldo Cruz 87, 299±304.
Voge, M. (1970) Concentration methods for helminth ova
and larvae. pp. 132±134 in MacInnis, A.J. & Voge, M.
(Eds) Experiments and techniques in parasitology.S a n
Francisco, WH Freeman.
Watanabe, N., Nawa, U., Okamoto, K. & Kobayashi, A.
(1994) Expulsion of Hymenolepis nana from mice with
congenital deficiencies of IgE production or of mast
cell development. Parasite Immunology 16, 137±144.
WHO (1996) Fighting disease fostering development.
The World Health Report. Geneva, World Health
Organization.
Yamaguti, S. (1959) Systema helminthum. The cestodes of
vertebrates. New York, Interscience.
Yan, G. & Norman, S. (1995) Infection of Tribolium beetles
with a tapeworm: variation in susceptibility within
and between beetle species and among genetic strains.
Journal of Parasitology 81, 37±42.
(Accepted 30 May 2001)
q CAB International, 2002
43 Infectivity of human R. nana to rodents